Literature DB >> 17986104

Nosocomial Acinetobacter pneumonia.

Carlos M Luna1, Patricia K Aruj.   

Abstract

Acinetobacter spp. (A. baumannii is the prevalent genomic species, but others may cause infection) has become an increasingly important cause of nosocomial pneumonia, particularly in mechanically ventilated patients (VAP). This organism has intrinsic resistance to some antimicrobials but easily acquires resistance to many others; Acinetobacter spp. can survive for long periods of time in the environment. All of these characteristics have contributed to protracted outbreaks associated with significant morbidity and mortality. High rates of colonization are found in debilitated hospitalized patients. Infecting or colonizing organisms in nosocomial infections are more likely to be from cross-transmission or from the hospital environment than from endogenous sources. VAP caused by Acinetobacter spp. is emerging as a prominent hospital complication. The incidence of this microorganism varies from site to site, but it is the second commonest aetiological agent among the gram-negative bacteria. Longer periods of hospitalization, longer time on mechanical ventilation and prior use of antibiotics are the recognized factors increasing the risk of VAP due to Acinetobacter spp. Treatment needs to clearly differentiate infection from colonization, and the agents with the most antimicrobial activity are imipenem/cilastatin, amikacin, colistin, ampicillin/sulbactam and tigecycline. Monotherapy can be adequate if the patient does not have significant comorbidities. Infection control procedures have a major role to play in preventing transmission of this microorganism. Emphasis on initial control measures should, however, be on strict isolation of infected or colonized patients to limit dissemination of outbreak strains in the environment. The variety of potential sources of contamination with Acinetobacter spp. in the hospital environment makes control of these outbreaks one of the more difficult challenges. Persistence of Acinetobacter spp. in the environment provides ample opportunities for contamination of patients and staff and may explain continuing long-term outbreaks.

Entities:  

Mesh:

Year:  2007        PMID: 17986104     DOI: 10.1111/j.1440-1843.2007.01147.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  13 in total

1.  Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents.

Authors:  Ebru Cakir Edis; Osman N Hatipoglu; Ozlem Tansel; Necdet Sut
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

Review 2.  Acinetobacter baumannii: an emerging opportunistic pathogen.

Authors:  Aoife Howard; Michael O'Donoghue; Audrey Feeney; Roy D Sleator
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

3.  Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs.

Authors:  Marie Kempf; Jean-Marc Rolain; Georges Diatta; Saïd Azza; Bissoum Samb; Oleg Mediannikov; Amy Gassama Sow; Seydina M Diene; Florence Fenollar; Didier Raoult
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

4.  Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.

Authors:  Azam F Tayabali; Kathy C Nguyen; Philip S Shwed; Jennifer Crosthwait; Gordon Coleman; Verner L Seligy
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

5.  Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice.

Authors:  Tadasu Iizumi; Takako Taniguchi; Wataru Yamazaki; Geraldine Vilmen; Alexander V Alekseyenko; Zhan Gao; Guillermo I Perez Perez; Martin J Blaser
Journal:  Gut Pathog       Date:  2016-11-18       Impact factor: 4.181

6.  Multiple lung abscesses due to acinetobacter infection: a case report.

Authors:  Ioannis Kokkonouzis; Ioannis Christou; Ioannis Athanasopoulos; Nikolaos Saridis; Vasilios Skoufaras
Journal:  Cases J       Date:  2009-12-18

7.  Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?

Authors:  Ya-Sung Yang; Yi-Tzu Lee; Tsai-Wang Huang; Jun-Ren Sun; Shu-Chen Kuo; Chin-Hsuan Yang; Te-Li Chen; Jung-Chung Lin; Chang-Phone Fung; Feng-Yee Chang
Journal:  BMC Infect Dis       Date:  2013-03-19       Impact factor: 3.090

8.  Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns.

Authors:  Hasan Ghajavand; Bahram Nasr Esfahani; Seyed Asghar Havaei; Sharareh Moghim; Hossein Fazeli
Journal:  Adv Biomed Res       Date:  2015-05-29

9.  Prevalence of Pseudomonas aeruginosa and Acinetobacter spp. in subgingival biofilm and saliva of subjects with chronic periodontal infection.

Authors:  Renata Souto; Carina M Silva-Boghossian; Ana Paula Vieira Colombo
Journal:  Braz J Microbiol       Date:  2014-08-29       Impact factor: 2.476

10.  Clinical and Economic Evaluation of Multidrug-Resistant Acinetobacter baumannii Colonization in the Intensive Care Unit.

Authors:  Hojin Lee; Hyuck Lee
Journal:  Infect Chemother       Date:  2016-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.